Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors – rationale and design of the “Beyond-SMuRFs Study”
Abstract Background Acute myocardial infarction (AMI) remains the leading cause of mortality worldwide. The majority of patients who suffer an AMI have a history of at least one of the standard modifiable risk factors (SMuRFs): smoking, hypertension, dyslipidemia, and diabetes mellitus. However, eme...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-03-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-023-03180-4 |
| _version_ | 1827956951614488576 |
|---|---|
| author | Dimitrios V. Moysidis Stylianos Daios Vasileios Anastasiou Alexandros C. Liatsos Andreas S. Papazoglou Efstratios Karagiannidis Vasileios Kamperidis Kali Makedou Aikaterini Thisiadou Paraskevi Karalazou Marios Papadakis Christos Savopoulos Antonios Ziakas George Giannakoulas Vassilios Vassilikos Georgios Giannopoulos |
| author_facet | Dimitrios V. Moysidis Stylianos Daios Vasileios Anastasiou Alexandros C. Liatsos Andreas S. Papazoglou Efstratios Karagiannidis Vasileios Kamperidis Kali Makedou Aikaterini Thisiadou Paraskevi Karalazou Marios Papadakis Christos Savopoulos Antonios Ziakas George Giannakoulas Vassilios Vassilikos Georgios Giannopoulos |
| author_sort | Dimitrios V. Moysidis |
| collection | DOAJ |
| description | Abstract Background Acute myocardial infarction (AMI) remains the leading cause of mortality worldwide. The majority of patients who suffer an AMI have a history of at least one of the standard modifiable risk factors (SMuRFs): smoking, hypertension, dyslipidemia, and diabetes mellitus. However, emerging scientific evidence recognizes a clinically significant and increasing proportion of patients presenting with AMI without any SMuRF (SMuRF-less patients). To date, there are no adequate data to define specific risk factors or biomarkers associated with the development of AMIs in these patients. Methods The ‘‘Beyond-SMuRFs Study’’ is a prospective, non-interventional cohort trial designed to enroll patients with AMI and no previous coronary intervention history, who undergo coronary angiography in two academic hospitals in Thessaloniki, Greece. The rationale of the study is to investigate potential relations between SMuRF-less AMIs and the clinical, laboratory and imaging profile of patients, by comparing parameters between patients with and without SMuRFs. Complete demographic and comprehensive clinical data will be recorded, Venous blood samples will be collected before coronary angiography and the following parameters will be measured: total blood count, standard biochemistry parameters, coagulation tests, hormone levels, glycosylated hemoglobin, N- terminal pro-B-type natriuretic peptide and high-sensitivity troponin T levels- as well as serum levels of novel atherosclerosis indicators and pro-inflammatory biomarkers. Furthermore, all participants will undergo a complete and comprehensive transthoracic echocardiographic assessment according to a pre-specified protocol within 24 h from admission. Among others, 2D-speckle-tracking echocardiographic analysis of cardiac chambers and non-invasive calculation of myocardial work indices for the left ventricle will be performed. Moreover, all patients will be assessed for angiographic parameters and the complexity of coronary artery disease using the SYNTAX score. Multivariable linear and logistic regression models will be used to phenotypically characterize SMuRF-less patients and investigate independent clinical, laboratory, echocardiographic and angiographic biomarkers-predictors of SMuRF-less status in AMI.The first patient was enrolled in March 2022 and completion of enrollment is expected until December 2023. Discussion The ‘‘Beyond-SmuRFs’’ study is an ongoing prospective trial aiming to investigate potential clinical, laboratory and imaging biomarkers associated with the occurrence of AMIs in SMuRF-less patients. The configuration of these patients’ profiles could lead to the development of personalized risk-stratification models predicting the occurrence of cardiovascular events in SΜuRF-less individuals. Trial Registration ClinicalTrials.gov Identifier: NCT05535582 / September 10, 2022. |
| first_indexed | 2024-04-09T15:12:35Z |
| format | Article |
| id | doaj.art-27a10aa1166c4191b5b897bf8266619a |
| institution | Directory Open Access Journal |
| issn | 1471-2261 |
| language | English |
| last_indexed | 2024-04-09T15:12:35Z |
| publishDate | 2023-03-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cardiovascular Disorders |
| spelling | doaj.art-27a10aa1166c4191b5b897bf8266619a2023-04-30T11:06:49ZengBMCBMC Cardiovascular Disorders1471-22612023-03-012311810.1186/s12872-023-03180-4Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors – rationale and design of the “Beyond-SMuRFs Study”Dimitrios V. Moysidis0Stylianos Daios1Vasileios Anastasiou2Alexandros C. Liatsos3Andreas S. Papazoglou4Efstratios Karagiannidis5Vasileios Kamperidis6Kali Makedou7Aikaterini Thisiadou8Paraskevi Karalazou9Marios Papadakis10Christos Savopoulos11Antonios Ziakas12George Giannakoulas13Vassilios Vassilikos14Georgios Giannopoulos15Third Department of Cardiology, Hippokration General Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of ThessalonikiFirst Department of Cardiology, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of ThessalonikiFirst Department of Cardiology, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of ThessalonikiFirst Department of Cardiology, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of ThessalonikiAthens Naval HospitalFirst Department of Cardiology, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of ThessalonikiFirst Department of Cardiology, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of ThessalonikiLaboratory of Biochemistry, Faculty of Health Sciences, School of Medicine, AHEPA General Hospital, Aristotle University of ThessalonikiLaboratory of Biochemistry, Faculty of Health Sciences, School of Medicine, AHEPA General Hospital, Aristotle University of ThessalonikiLaboratory of Biochemistry, Faculty of Health Sciences, School of Medicine, AHEPA General Hospital, Aristotle University of ThessalonikiUniversity Hospital Witten-Herdecke, University of Witten-HerdeckeUniversity Hospital Witten-Herdecke, University of Witten-HerdeckeFirst Department of Cardiology, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of ThessalonikiFirst Department of Cardiology, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of ThessalonikiThird Department of Cardiology, Hippokration General Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of ThessalonikiThird Department of Cardiology, Hippokration General Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of ThessalonikiAbstract Background Acute myocardial infarction (AMI) remains the leading cause of mortality worldwide. The majority of patients who suffer an AMI have a history of at least one of the standard modifiable risk factors (SMuRFs): smoking, hypertension, dyslipidemia, and diabetes mellitus. However, emerging scientific evidence recognizes a clinically significant and increasing proportion of patients presenting with AMI without any SMuRF (SMuRF-less patients). To date, there are no adequate data to define specific risk factors or biomarkers associated with the development of AMIs in these patients. Methods The ‘‘Beyond-SMuRFs Study’’ is a prospective, non-interventional cohort trial designed to enroll patients with AMI and no previous coronary intervention history, who undergo coronary angiography in two academic hospitals in Thessaloniki, Greece. The rationale of the study is to investigate potential relations between SMuRF-less AMIs and the clinical, laboratory and imaging profile of patients, by comparing parameters between patients with and without SMuRFs. Complete demographic and comprehensive clinical data will be recorded, Venous blood samples will be collected before coronary angiography and the following parameters will be measured: total blood count, standard biochemistry parameters, coagulation tests, hormone levels, glycosylated hemoglobin, N- terminal pro-B-type natriuretic peptide and high-sensitivity troponin T levels- as well as serum levels of novel atherosclerosis indicators and pro-inflammatory biomarkers. Furthermore, all participants will undergo a complete and comprehensive transthoracic echocardiographic assessment according to a pre-specified protocol within 24 h from admission. Among others, 2D-speckle-tracking echocardiographic analysis of cardiac chambers and non-invasive calculation of myocardial work indices for the left ventricle will be performed. Moreover, all patients will be assessed for angiographic parameters and the complexity of coronary artery disease using the SYNTAX score. Multivariable linear and logistic regression models will be used to phenotypically characterize SMuRF-less patients and investigate independent clinical, laboratory, echocardiographic and angiographic biomarkers-predictors of SMuRF-less status in AMI.The first patient was enrolled in March 2022 and completion of enrollment is expected until December 2023. Discussion The ‘‘Beyond-SmuRFs’’ study is an ongoing prospective trial aiming to investigate potential clinical, laboratory and imaging biomarkers associated with the occurrence of AMIs in SMuRF-less patients. The configuration of these patients’ profiles could lead to the development of personalized risk-stratification models predicting the occurrence of cardiovascular events in SΜuRF-less individuals. Trial Registration ClinicalTrials.gov Identifier: NCT05535582 / September 10, 2022.https://doi.org/10.1186/s12872-023-03180-4Coronary artery diseaseAcute coronary syndromeStandard modifiable risk factorsSmuRFsPredictive biomarkersPersonalized medicine |
| spellingShingle | Dimitrios V. Moysidis Stylianos Daios Vasileios Anastasiou Alexandros C. Liatsos Andreas S. Papazoglou Efstratios Karagiannidis Vasileios Kamperidis Kali Makedou Aikaterini Thisiadou Paraskevi Karalazou Marios Papadakis Christos Savopoulos Antonios Ziakas George Giannakoulas Vassilios Vassilikos Georgios Giannopoulos Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors – rationale and design of the “Beyond-SMuRFs Study” BMC Cardiovascular Disorders Coronary artery disease Acute coronary syndrome Standard modifiable risk factors SmuRFs Predictive biomarkers Personalized medicine |
| title | Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors – rationale and design of the “Beyond-SMuRFs Study” |
| title_full | Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors – rationale and design of the “Beyond-SMuRFs Study” |
| title_fullStr | Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors – rationale and design of the “Beyond-SMuRFs Study” |
| title_full_unstemmed | Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors – rationale and design of the “Beyond-SMuRFs Study” |
| title_short | Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors – rationale and design of the “Beyond-SMuRFs Study” |
| title_sort | association of clinical laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors rationale and design of the beyond smurfs study |
| topic | Coronary artery disease Acute coronary syndrome Standard modifiable risk factors SmuRFs Predictive biomarkers Personalized medicine |
| url | https://doi.org/10.1186/s12872-023-03180-4 |
| work_keys_str_mv | AT dimitriosvmoysidis associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT stylianosdaios associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT vasileiosanastasiou associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT alexandroscliatsos associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT andreasspapazoglou associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT efstratioskaragiannidis associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT vasileioskamperidis associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT kalimakedou associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT aikaterinithisiadou associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT paraskevikaralazou associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT mariospapadakis associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT christossavopoulos associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT antoniosziakas associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT georgegiannakoulas associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT vassiliosvassilikos associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy AT georgiosgiannopoulos associationofclinicallaboratoryandimagingbiomarkerswiththeoccurrenceofacutemyocardialinfarctioninpatientswithoutstandardmodifiableriskfactorsrationaleanddesignofthebeyondsmurfsstudy |